Inactive Instrument
Ceapro Inc. Stock
Stocks
CZO
CA1499071076
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -11.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 72 | 21/06/2012 |
| Director of Finance/CFO | - | - | |
Mitch Regnier
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Gagnon
BRD | Director/Board Member | 72 | 01/01/2007 |
William Li
BRD | Director/Board Member | 63 | 20/11/2014 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 28/04/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/7/24 A | Marche | Chief Executive Officer | 250,000 | 0.3193% | ||
| 6/7/24 A | Marche | Chief Financial Officer | 32,500 | 0.0415% | ||
| 6/7/24 A | Marche | Director | 230,000 | 0.2938% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -11.76% | -16.67% | - | - | 12.8M | ||
| +0.52% | +6.46% | +0.52% | +14.25% | 48.95B | ||
| +1.90% | +24.70% | +27.25% | +9.47% | 40.75B | ||
| -1.60% | -1.15% | +388.84% | +603.70% | 38.46B | ||
| -0.98% | +2.28% | +7.02% | +45.34% | 36.38B | ||
| +1.47% | +5.82% | +5.76% | +43.52% | 28.45B | ||
| -0.94% | +0.05% | - | - | 16.62B | ||
| +2.44% | +10.76% | +30.59% | +129.56% | 16.33B | ||
| -1.14% | +6.52% | -3.80% | -29.33% | 13.65B | ||
| +0.17% | +3.99% | +4.06% | +9.88% | 13.56B | ||
| Average | -0.99% | +5.79% | +57.53% | +103.30% | 28.13B | |
| Weighted average by Cap. | +0.23% | +6.92% | +71.93% | +122.78% |
Employees
-
















